Viral Vectors in Tumors: Effects of Taxol and Radiation
肿瘤中的病毒载体:紫杉醇和辐射的影响
基本信息
- 批准号:7224811
- 负责人:
- 金额:$ 26.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-07-01 至 2009-04-30
- 项目状态:已结题
- 来源:
- 关键词:AdenovirusesAntineoplastic AgentsApoptosisApoptoticBlood VesselsBreast CarcinomaCell ProliferationCellsCessation of lifeChemicalsChondroitin SulfatesChondroitinasesCollagenCollagen Type IConfined SpacesCytotoxic agentDataDependovirusDepositionDiffusionEnzymesFatty acid glycerol estersFluorescence Recovery After PhotobleachingFrozen SectionsGelGene TransferGenesGlycosaminoglycansGoldGrowthHerpesvirus 1HyaluronanHyaluronidaseImmunodeficient MouseImmunohistochemistryImplantIn VitroInduction of ApoptosisInhibition of ApoptosisIntercellular FluidLaser Scanning MicroscopyLocalizedMalignant Epithelial CellMammary NeoplasmsMammary glandMeasurementMeasuresMethodsMicroscopyMolecularMovementMusMuscle RigidityNoduleNon-Viral VectorNumbersObstructionPaclitaxelPathway interactionsPenetrationPerfusionPlatelet-Derived Growth FactorPrincipal InvestigatorProcessProductionProtein OverexpressionRadiationReactionRelative (related person)Research PersonnelRoleSCID MiceSepharoseSilverSilver StainingSimulateSolutionsStaining methodStainsStromal CellsTechniquesTestingTetracyclineTetracyclinesTherapeutic AgentsTimeTissuesTransfectionTransforming Growth FactorsTransgenesUrinationViralViral VectorVirusWestern Blottingbasecaspase-8clinically relevantcollagenasecytokinefluid flowgene therapyhyaluronan synthase 1improvedin vivoinsightinterstitialintravenous injectionneoplastic cellparticlepolysulfated glycosaminoglycanprogramspromoterradiation effectsizesuccesstumortumor growth
项目摘要
DESCRIPTION (provided by applicant):
The proliferation of neoplastic cells in a confined space collapses blood vessels thus restricting the penetration and uniform distribution of therapeutic agents in tumors. Our recent data also shows that growth of tumor spheroids in a confined space can upregulate the expression of hyaluronan an interstitial matrix (IM) molecule that hinders interstitial fluid movement and molecular diffusion. The induction of apoptosis by taxol alleviates the confined space effects, thus improving vascular perfusion and fluid flow through the tumor IM. In contrast, radiation reduces fluid flow through the tumor IM. Thus the objectives of the proposed study will be to determine: 1) the effects of taxol and radiation on interstitial transport, and on the production of IM molecules, 2) test the hypothesis that growth in a confined space upregulates the expression of glycosaminoglycans by tumor cells and reduces diffusive transport and 3) determine if the void spaces induced by apoptosis produce interstitial pathways that favor a rapid and more uniform penetration of viruses. Fluorescence recovery after photobleaching and measurements of hydraulic conductivity will test the hypothesis that taxol enhances interstitial transport in tumors. The transport data will be related to the levels of IM matrix molecules and apoptosis. The effects of growth in a confined space on the expression of hyaluronan will be tested in
vitro by growing tumor spheroids in increasing concentrations of collagen or agarose gels. To test the hypothesis that apoptosis enhances the distribution volume of viral particles and gene transfection in tumors, apoptosis will be induced with taxol and in cells transfected with a caspase-8 inducible promoter. Multiphoton laser-scanning microscopy will be used to measure in tumors the distribution volume of viral vectors and determine if the void spaces induced by apoptosis form interconnected interstitial pathways that enhance the movement of viral particles. Sense constructs of hyaluronan synthase 2 will test the hypothesis that hyaluronan participates in the remodeling and obstruction of the void spaces following apoptotic death, thus reducing interstitial transport and the movement of viral vectors. The hypothesis that taxol-induced apoptosis (void space formation) enhances the antitumor efficacy of gene therapy will be tested. The results will provide insight on how to best combine viral vectors and cytotoxic agents.
描述(由申请人提供):
肿瘤细胞在有限空间中的增殖使血管塌陷,从而限制了治疗剂在肿瘤中的渗透和均匀分布。我们最近的数据还表明,肿瘤球状体在有限空间中的生长可以上调透明质酸的表达,透明质酸是一种阻碍间质液运动和分子扩散的间质基质(IM)分子。紫杉醇诱导的细胞凋亡消除了受限空间效应,从而改善了肿瘤IM的血管灌注和液体流动。相比之下,放射减少了通过肿瘤IM的流体流动。 因此,拟议研究的目标是确定:1)紫杉醇和辐射对间质转运和IM分子产生的影响,2)检验在有限空间中生长上调肿瘤细胞的糖胺聚糖表达并减少扩散转运的假设,以及3)确定细胞凋亡诱导的空隙空间是否产生有利于病毒快速和更均匀渗透的间质途径。光漂白后的荧光恢复和水力传导率的测量将检验紫杉醇增强肿瘤间质转运的假设。转运数据将与IM基质分子和细胞凋亡的水平相关。在有限空间中生长对透明质酸表达的影响将在
通过在增加浓度的胶原蛋白或琼脂糖凝胶中生长肿瘤球状体来进行体外培养。为了检验细胞凋亡增强肿瘤中病毒颗粒的分布体积和基因转染的假设,将用紫杉醇和用半胱天冬酶-8诱导型启动子转染的细胞诱导细胞凋亡。多光子激光扫描显微镜将用于测量肿瘤中病毒载体的分布体积,并确定细胞凋亡诱导的空隙空间是否形成相互连接的间质通路,从而增强病毒颗粒的运动。透明质酸合酶2的正义构建体将检验以下假设:透明质酸参与凋亡性死亡后空隙空间的重塑和阻塞,从而减少病毒载体的间质转运和移动。紫杉醇诱导的细胞凋亡(空隙形成)增强基因治疗的抗肿瘤功效的假设将被检验。这些结果将为如何最好地结合联合收割机病毒载体和细胞毒性剂提供见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YVES BOUCHER其他文献
YVES BOUCHER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YVES BOUCHER', 18)}}的其他基金
Reprogramming PDAC tumor microenvironment to improve immunotherapy
重编程 PDAC 肿瘤微环境以改善免疫治疗
- 批准号:
10242459 - 财政年份:2017
- 资助金额:
$ 26.88万 - 项目类别:
Reprogramming PDAC tumor microenvironment to improve immunotherapy
重编程 PDAC 肿瘤微环境以改善免疫治疗
- 批准号:
10251378 - 财政年份:2017
- 资助金额:
$ 26.88万 - 项目类别:
Breakdown of Desmoplasia in Pancreatic Cancer to Enhance Drug Effectiveness
分解胰腺癌中的结缔组织增生以增强药物疗效
- 批准号:
8584053 - 财政年份:2013
- 资助金额:
$ 26.88万 - 项目类别:
Breakdown of Desmoplasia in Pancreatic Cancer to Enhance Drug Effectiveness
分解胰腺癌中的结缔组织增生以增强药物疗效
- 批准号:
8695305 - 财政年份:2013
- 资助金额:
$ 26.88万 - 项目类别:
Viral Vectors in Tumors: Effects of Taxol and Radiation
肿瘤中的病毒载体:紫杉醇和辐射的影响
- 批准号:
6768821 - 财政年份:2003
- 资助金额:
$ 26.88万 - 项目类别:
Transport of Large Molecules and Viral Vectors in Tumors: Effects of Cytotoxic an
肿瘤中大分子和病毒载体的转运:细胞毒性和病毒载体的影响
- 批准号:
8256700 - 财政年份:2003
- 资助金额:
$ 26.88万 - 项目类别:
Transport of Large Molecules and Viral Vectors in Tumors: Effects of Cytotoxic an
肿瘤中大分子和病毒载体的转运:细胞毒性和病毒载体的影响
- 批准号:
8054267 - 财政年份:2003
- 资助金额:
$ 26.88万 - 项目类别:
Viral Vectors in Tumors: Effects of Taxol and Radiation
肿瘤中的病毒载体:紫杉醇和辐射的影响
- 批准号:
6898398 - 财政年份:2003
- 资助金额:
$ 26.88万 - 项目类别:
Transport of Large Molecules and Viral Vectors in Tumors: Effects of Cytotoxic an
肿瘤中大分子和病毒载体的转运:细胞毒性和病毒载体的影响
- 批准号:
8458984 - 财政年份:2003
- 资助金额:
$ 26.88万 - 项目类别:
Transport of Large Molecules and Viral Vectors in Tumors: Effects of Cytotoxic an
肿瘤中大分子和病毒载体的转运:细胞毒性和病毒载体的影响
- 批准号:
7869366 - 财政年份:2003
- 资助金额:
$ 26.88万 - 项目类别:
相似海外基金
Delays in Acquisition of Oral Antineoplastic Agents
口服抗肿瘤药物的获取延迟
- 批准号:
9975367 - 财政年份:2020
- 资助金额:
$ 26.88万 - 项目类别:
Eliminate the difficulty of venous puncture in patients receiving antineoplastic agents - Development of a new strategy for the prevention of induration-
消除接受抗肿瘤药物的患者静脉穿刺的困难 - 制定预防硬结的新策略 -
- 批准号:
16K11932 - 财政年份:2016
- 资助金额:
$ 26.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of the antineoplastic agents inhibiting DNA replication and their applications to cancer patient treatmen
抗肿瘤药物抑制DNA复制的分子机制及其在癌症患者治疗中的应用
- 批准号:
19591274 - 财政年份:2007
- 资助金额:
$ 26.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
PNET EXPERIMENTAL THERAPEUTICS--ANTINEOPLASTIC AGENTS AND TREATMENT DELIVERY
PNET 实验治疗——抗肿瘤药物和治疗实施
- 批准号:
6346309 - 财政年份:2000
- 资助金额:
$ 26.88万 - 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
- 批准号:
2885074 - 财政年份:1999
- 资助金额:
$ 26.88万 - 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
- 批准号:
6174221 - 财政年份:1999
- 资助金额:
$ 26.88万 - 项目类别: